Are you looking to maximize the efficiency of your product development process? Join THBD for our June E-Learning Series webinar as Brent Moody, Principal Scientist of Catalent Pharma Solutions, provides insight into how to classify new therapeutic drug candidates for issues related to oral product development. Based on his 24 years’ experience in the biopharma industry, Brent offers guidance for startups and emphasizes the need to anticipate and address challenges to plan for successful preclinical and early-stage clinical studies.

This webinar will cover the principles of drug delivery, how to assess the developability of a new therapeutic small molecule for oral dosing, selecting the best clinical dosing strategy for your molecule, and the impact of early formulation decisions on timelines and costs.

Join us for an informative session you can’t afford to miss!